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Background
During HIV-1 infection, an increase of indoleamine 2,3
dioxygenase (IDO) expression, and dendritic cells (DC)
dysfunction were often associated with AIDS disease
progression [1].
Materials and methods
In this work, we investigated the effect of Tat recombi-
nant protein from HIV-1 Lai and SF-2 strains on the
expression of IDO, in Monocyte-derived dendritic cells
(MoDCs) generated following 5 days of culture in the
presence of GM-CSF and IL-4. IDO expression was ana-
lysed by SDS-PAGE and western blotting, intracellular
labelling or by measuring kynurenine production by
Ehrlich’s assay. The capacity of Tat-treated MoDC to
stimulate T cell proliferation was analysed by following
CFSE dilution in the presence or absence of IDO inhibi-
tor (1-methyl-tryptophane).
Results
We show that Tat induces IDO protein expression and
activity in a dose dependent manner by acting at the
cell membrane level. Using different Tat-fragments, we
show that the N-Terminal domain, Tat 1-45, but not
the central region, Tat 30-72, is sufficient to induce the
expression of active IDO. Tat protein is also able to
induce several cytokines in MoDCs, including IFN-g, a
strong inducer of IDO. In order to understand whether
IDO is induced directly by Tat protein or indirectly fol-
lowing IFN-g production, complementary experiments
were performed and showed that: i) at the kinetic level,
Tat induced IDO expression before the production of
IFN-g ii) treatment of MoDCs with Tat-conditioned
medium was unable to stimulate IDO expression, iii)
coculture of MoDCs in a transwell cell system did not
allow IDO expression in MoDCs not previously treated
by Tat, iv) direct contact between Tat-treated and
untreated MoDCs was not sufficient to induce IDO
expression in a Tat-independent manner, and v) treat-
ment of MoDCs in the presence of IFN-g pathway inhi-
bitors, Jak I and Ly294002, inhibited IFN-g-induced IDO
but had no effect on Tat-induced IDO. At the functional
level, our data showed that treatment of MoDCs with
Tat led to the inhibition of their capacity to stimulate T
cell proliferation. This impairement was totally abolished
when the stimulation was performed in the presence of
1MT, an inhibitor of IDO activity, arguing for the impli-
cation of the kynurenine pathway.
Conclusions
By inducing IDO, Tat protein may be considered, as a
viral pathogenic factor, in the dysregulation of the DC
functions during HIV-1 infection.
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